The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Abstract
Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ang II binds the ATR1 (Ang II receptor 1) receptor leading to release of TNF α and IL-6, 55 which is associated with hypertension, diabetes, and heart disease 52,56,57 -major comorbidities in severe COVID-19.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [52]
In the citing paper
“ACE2 not only functions as a viral receptor for SARSCoV-2 but also regulates blood pressure.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [52]
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citationGlobal Burden of Cardiovascular Diseases
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 3,014
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
Spradling, A. C., Stern, D., Beaton, A., Rehm, E. J., Laverty, T., Mozden, N., Misra, S., & Rubin, G. M. (1999) · Genetics · doi:10.1093/genetics/153.1.135 · Cited by 781
Sowter, H., Ratcliffe, P. J., Watson, P. H., Greenberg, A. H., & Harris, A. L. (2001) · PubMed · Cited by 705
Male–female differences in fertility and blood pressure in ACE-deficient mice
Krege, J. H., John, S. W. M., Langenbach, L. L., Hodgin, J. B., Hagaman, J. R., Bachman, E. S., Jennette, J. C., O’Brien, D. A., & Smithies, O. (1995) · Nature · doi:10.1038/375146a0 · Cited by 646
Hilbert, P., Lindpaintner, K., Beckmann, J. S., Serikawa, T., Soubrier, F., Dubay, C., Cartwright, P., Gouyon, B., Julier, C., Takahasi, S., et al. (1991) · Nature · doi:10.1038/353521a0 · Cited by 609
NK-2Homeobox Genes and Heart Development
Harvey, R. P. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0212 · Cited by 579
Characterization and localization of the even‐skipped protein of Drosophila.
Frasch, M., Hoey, T. C., Rushlow, C. A., Doyle, H. J., & Levine, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04817.x · Cited by 486
Esther, C. R., Howard, T. E., Marino, E. M., Goddard, J. M., Capecchi, M. R., & Bernstein, K. E. (1996) · PubMed · Cited by 440
Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning
Kloner, R. A., Bolli, R., Marbán, E., Reinlib, L., & D, E. B. M. (1998) · Circulation · doi:10.1161/01.cir.97.18.1848 · Cited by 438
Genetic Analysis of Inherited Hypertension in the Rat
Rapp, J. P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.135 · Cited by 421
Giordano, F. J., Gerber, H., Williams, S., van Bruggen, N., Bunting, S., Ruiz‐Lozano, P., Gu, Y., Nath, A. K., Huang, Y., Hickey, R. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091415198 · Cited by 370
Angiotensinogen-deficient mice with hypotension.
Tanimoto, K., Sugiyama, F., Goto, Y., Ishida, J., Takimoto, E., Yagami, K.-I., Fukamizu, A., & Murakami, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31697-1 · Cited by 369
Kietzmann, T., Roth, U., & Jungermann, K. A. (1999) · Blood · doi:10.1182/blood.v94.12.4177 · Cited by 256
Transgenic Mouse Model of Stunned Myocardium
Murphy, A. M., Kögler, H., Georgakopoulos, D., McDonough, J. L., Kass, D. A., Van Eyk, J. E., & Marbán, E. (2000) · Science · doi:10.1126/science.287.5452.488 · Cited by 228
Segmentation and specification of the Drosophila mesoderm.Preprint
Azpiazu, N., Lawrence, P. A., Vincent, J. P., & Frasch, M. (1996) · Genes & Development · doi:10.1101/gad.10.24.3183 · Cited by 200
Heusch, G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1055 · Cited by 182
A Genomic-Systems Biology Map for Cardiovascular Function
Stoll, M., Cowley, A. W., Tonellato, P. J., Greene, A. S., Kaldunski, M. L., Roman, R. J., Dumas, P., Schork, N. J., Wang, Z., & Jacob, H. J. (2001) · Science · doi:10.1126/science.1062117 · Cited by 168
Cornell, M. J., Williams, T. A., Lamango, N. S., Coates, D., Corvol, P. L., Soubrier, F., Hoheisel, J. D., Lehrach, H. R., & Isaac, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13613 · Cited by 156
Stroke Risk Factors and Stroke Prevention
Elkind, M., & Sacco, R. L. (1998) · Seminars in Neurology · doi:10.1055/s-2008-1040896 · Cited by 144
Differential actions of renal ischemic injury on the intrarenal angiotensin system
Allred, A. J., Chappell, M. C., Ferrario, C. M., & Diz, D. I. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f636 · Cited by 113
Self-citationEvidence for an intrinsic angiotensin system in the canine pancreas
Chappell, M. C., Millsted, A., Diz, D. I., Brosnihan, K. B., & Ferrario, C. M. (1991) · Journal of Hypertension · doi:10.1097/00004872-199108000-00008 · Cited by 110
Self-citationTargeted Expression of a Dominant-Negative K v 4.2 K + Channel Subunit in the Mouse Heart
Wickenden, A. D., Lee, P. C., Sah, R., Huang, Q., Fishman, G. I., & Backx, P. H. (1999) · Circulation Research · doi:10.1161/01.res.85.11.1067 · Cited by 106
Self-citationCombinatorial interactions regulating cardiac transcription
Durocher, D., & Nemer, M. J. (1998) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1998)22:3 · Cited by 101
Zvaritch, E., Backx, P. H., Jirik, F. R., Kimura, Y., de Leon, S., Schmidt, A. G., Hoit, B. D., Lester, J. W., Kranias, E. G., & MacLennan, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14985 · Cited by 92
Self-citationThe Biochemistry of the Renin-Angiotensin System
Skeggs, L. T., Dorer, F. E., Levine, M., Lentz, K. E., & Kahn, J. R. (1980) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-9173-3_1 · Cited by 89
Enseleit, F., Hürlimann, D., & Lüscher, T. F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200109011-00004 · Cited by 63
Yagil, C., Katni, G., Rubattu, S., Stolpe, C., Kreutz, R. H., Lindpaintner, K., Ganten, D., Ben-lshay, D., & Yagil, Y. (1996) · Journal of Hypertension · doi:10.1097/00004872-199610000-00004 · Cited by 53
Self-citationThe Acer gene of Drosophila codes for an angiotensin-converting enzyme homologue
Taylor, C. A., Coates, D., & Shirras, A. D. (1996) · Gene · doi:10.1016/s0378-1119(96)00503-3 · Cited by 53
Cloning, Characterization, and Genetic Mapping of the Rat Type 2 Angiotensin II Receptor Gene
Koike, G., Winer, E. S., Horiuchi, M., Brown, D. M., Szpirer, C., Dzau, V. J., & Jacob, H. J. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.998 · Cited by 39
Role of Chromosome X in the Sabra Rat Model of Salt-Sensitive Hypertension
Yagil, C., Sapojnikov, M., Kreutz, R. H., Zürcher, H., Ganten, D., & Yagil, Y. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.261 · Cited by 38
Self-citationRenovascular hypertension: a paradigm for all hypertension.
LARAGH, J. H. (1986) · PubMed · Cited by 22
PHYSIOLOGICAL GENETICS: APPLICATION TO HYPERTENSION RESEARCH
Jacob, H. J. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03078.x · Cited by 20
Metabolic features of newly established congenic diabetes-prone BB.SHR rat strains
Klöting, I., Voigt, B., & Kovacs, P. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00017-4 · Cited by 15
Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism: Clinical Implications
Wuyts, B., Delanghe, J. R., & Buyzere, M. D. (1997) · Acta Clinica Belgica · doi:10.1080/17843286.1997.11718599 · Cited by 12
Angiotensin converting enzyme inhibiton and the kidney
Hollenberg, N. K. (1988) · Current Opinion in Cardiology · doi:10.1097/00001573-198801001-00003 · Cited by 6
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,036
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Self-citationMechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022
Metadata
- Authors
- Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C. M., Manoukian, A. S., Chappell, M. C., Backx, P. H., Yagil, Y., & Penninger, J. M.
- Affiliations
- University of Toronto (CA)
- Institute of Molecular Biotechnology (AT)
- University Health Network (CA)
- Barzilai Medical Center (IL)
- Atrium Health Wake Forest Baptist (US)
- Corresponding author
- Penninger, Josef M.
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6891
- Pages
- 822-828
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2025672718
- Cited by
- 1,733
- References
- 44
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 38 · 2023: 88 · 2022: 117 · 2021: 215 · 2020: 311 · 2019: 38 · 2018: 22 · 2017: 33 · 2016: 42 · 2015: 38 · 2014: 53 · 2013: 54 · 2012: 60
- FWCI
- 38.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Amgen
- German-Israeli Foundation for Scientific Research and Development
- Canada Research Chairs
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- angiotensin-converting enzyme 2, ACE2, cardiac function, hypertension, quantitative trait loci, X chromosome, cardiac contractility, angiotensin II, hypoxia, Acer, cardiac morphogenesis, rat model, mouse knockout
- MeSH terms
- Angiotensin II, Animals, Hypoxia, Blood Pressure, Cloning, Molecular, Drosophila melanogaster, Female, Heart, Hypertension, Peptidyl-Dipeptidase A, Male, Metalloendopeptidases, Myocardial Contraction, Myocardium, X Chromosome, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Quantitative Trait, Heritable, Radiation Hybrid Mapping, Drosophila Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review